|
1
|
Kobayashi E, Hornicek FJ and Duan Z:
MicroRNA involvement in osteosarcoma. Sarcoma. 2012:3597392012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruland OS, Bauer H, Alvegaard T and
Smeland S: Treatment of osteosarcoma. The Scandinavian Sarcoma
Group experience. Cancer Treat Res. 152:309–318. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM
and Zhang GZ: Biological functions of microRNAs: A review. J
Physiol Biochem. 67:129–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sotillo E and Thomas-Tikhonenko A:
Shielding the messenger (RNA): microRNA-based anticancer therapies.
Pharmacol Ther. 131:18–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng N, Miao Z, Wang L, Liu B, Wang G and
Guo X: MiR-378 promotes the cell proliferation of osteosarcoma
through down-regulating the expression of Kruppel-like factor 9.
Biochem Cell Biol. 96:515–521. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Z, Li Q, Zhao X, Cui B, Zhang L and
Wang Q: MicroRNA-935 inhibits proliferation and invasion of
osteosarcoma cells by directly targeting High mobility group box 1.
Oncol Res. Feb 22–2018. View Article : Google Scholar
|
|
9
|
Yang X, Wang L, Wang Q, Li L, Fu Y and Sun
J: MiR-183 inhibits osteosarcoma cell growth and invasion by
regulating LRP6-Wnt/β-catenin signaling pathway. Biochem Biophys
Res Commun. 496:1197–1203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong J, Liu Y, Liao W, Liu R, Shi P and
Wang L: miRNA-223 is a potential diagnostic and prognostic marker
for osteosarcoma. J Bone Oncol. 5:74–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng L, Ma J, Ji H, Liu Y and Hu W:
miR-330-5p suppresses glioblastoma cell proliferation and
invasiveness through targeting ITGA5. Biosci Rep. 37(pii):
BSR201700192017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Trehoux S, Lahdaoui F, Delpu Y, Renaud F,
Leteurtre E, Torrisani J, Jonckheere N and Van Seuningen I:
Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by
targeting the MUC1 mucin in pancreatic cancer cells. Biochim
Biophys Acta. 1853:2392–2403. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H, Chen SH, Kong P, Zhang LY, Zhang
LL, Zhang NQ and Gu H: Increased expression of miR-330-3p: A novel
independent indicator of poor prognosis in human breast cancer. Eur
Rev Med Pharmacol Sci. 22:1726–1730. 2018.PubMed/NCBI
|
|
14
|
Su BB, Zhou SW, Gan CB and Zhang XN:
MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses
cell proliferation and invasion in cutaneous malignant melanoma. J
Surg Res. 203:434–440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei CH, Wu G, Cai Q, Gao XC, Tong F, Zhou
R, Zhang RG, Dong JH, Hu Y and Dong XR: MicroRNA-330-3p promotes
cell invasion and metastasis in non-small cell lung cancer through
GRIA3 by activating MAPK/ERK signaling pathway. J Hematol Oncol.
10:1252017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim BK, Yoo HI, Choi K and Yoon SK:
miR-330-5p inhibits proliferation and migration of keratinocytes by
targeting Pdia3 expression. FEBS J. 282:4692–4702. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kong R, Liu W, Guo Y, Feng J, Cheng C,
Zhang X, Ma Y, Li S, Jiang J, Zhang J, et al: Inhibition of NOB1 by
microRNA-330-5p overexpression represses cell growth of non-small
cell lung cancer. Oncol Rep. 38:2572–2580. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT,
Goan YG and Lu PJ: MicroRNA-330 acts as tumor suppressor and
induces apoptosis of prostate cancer cells through E2F1-mediated
suppression of Akt phosphorylation. Oncogene. 28:3360–3370. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qu S, Yao Y, Shang C, Xue Y, Ma J, Li Z
and Liu Y: MicroRNA-330 is an oncogenic factor in glioblastoma
cells by regulating SH3GL2 gene. PLoS One. 7:e460102012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao Y, Xue Y, Ma J, Shang C, Wang P, Liu
L, Liu W, Li Z, Qu S, Li Z and Liu Y: MiR-330-mediated regulation
of SH3GL2 expression enhances malignant behaviors of glioblastoma
stem cells by activating ERK and PI3K/AKT signaling pathways. PLoS
One. 9:e950602014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luk SU, Xue H, Cheng H, Lin D, Gout PW,
Fazli L, Collins CC, Gleave ME and Wang Y: The BIRC6 gene as a
novel target for therapy of prostate cancer: Dual targeting of
inhibitors of apoptosis. Oncotarget. 5:6896–6908. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kusner LL, Ciesielski MJ, Marx A, Kaminski
HJ and Fenstermaker RA: Survivin as a potential mediator to support
autoreactive cell survival in myasthenia gravis: A human and animal
model study. PLoS One. 9:e1022312014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang HX, Chen G, Li GL and Jiang YJ:
Expression and significance of Survivin and Smac in ovarian
mucinous tumors. Zhonghua Bing Li Xue Za Zhi. 39:387–390. 2010.(In
Chinese). PubMed/NCBI
|
|
25
|
Wang H and Ye YF: Effect of survivin siRNA
on biological behaviour of breast cancer MCF7 cells. Asian Pac J
Trop Med. 8:225–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen X, Chen XG, Hu X, Song T, Ou X and
Zhang C, Zhang W and Zhang C: MiR-34a and miR-203 Inhibit survivin
expression to control cell proliferation and survival in human
osteosarcoma cells. J Cancer. 7:1057–1065. 2016. View Article : Google Scholar : PubMed/NCBI
|
